|
Eisai
|
3,912.00 |
|
-13.00 |
-0.33% |
-35.41% |
2025-04-03 |
|
ALKERMES
|
32.58 |
|
0.05 |
0.15% |
23.74% |
2025-04-02 |
|
Alnylam Pharmaceuticals
|
267.03 |
|
11.27 |
4.41% |
77.04% |
2025-04-02 |
|
Amarin
|
0.44 |
|
-0.003 |
-0.61% |
-58.56% |
2025-04-02 |
|
ANI Pharmaceuticals
|
69.36 |
|
1.34 |
1.97% |
3.15% |
2025-04-02 |
|
Arrowhead Research
|
12.69 |
|
0.48 |
3.93% |
-52.08% |
2025-04-02 |
|
GlaxoSmithKline
|
1,433.50 |
|
-35.50 |
-2.42% |
-13.33% |
2025-04-02 |
|
Insmed
|
73.42 |
|
1.42 |
1.97% |
165.25% |
2025-04-02 |
|
Ligand Pharmaceuticals
|
108.73 |
|
3.91 |
3.73% |
45.50% |
2025-04-02 |
|
Merck
|
86.61 |
|
-0.47 |
-0.54% |
-33.33% |
2025-04-02 |
|
Neurocrine Biosciences
|
108.24 |
|
1.24 |
1.16% |
-21.33% |
2025-04-02 |
|
Pacira
|
24.89 |
|
0.82 |
3.41% |
-14.20% |
2025-04-02 |
|
Ultragenyx Pharmaceutical
|
35.37 |
|
1.53 |
4.52% |
-24.87% |
2025-04-02 |
|
Regeneron Pharmaceuticals
|
625.48 |
|
8.52 |
1.38% |
-34.23% |
2025-04-02 |
|
Roche Holding
|
286.80 |
|
-5.60 |
-1.92% |
26.68% |
2025-04-02 |
|
Veracyte
|
30.13 |
|
0.57 |
1.93% |
46.05% |
2025-04-02 |
|
Vertex Pharmaceuticals
|
483.45 |
|
-1.28 |
-0.26% |
18.26% |
2025-04-02 |